Related Experiment Video
Updated: Aug 14, 2026

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
Published on: November 11, 2018
[Rhabdomyolysis as a side effect of simvastatin treatment]
Bosiljka Iskra1, Marijana Zivko, Petar Kes
1Interni odjel, Opća bolnica Virovitica, Virovitica, Hrvatska.
Abstract:
Myopathy and rhabdomyolysis are rare adverse effects of treatment with hydroxymethylglutaryl-coA reductase inhibitors. The risk of adverse effects is increased with the concomitant use of statin and specific drugs that can induce myopathy, in patients with liver and renal function impairment, hypothyroidism and diabetes mellitus. The clinical picture of rhabdymyolysis with acute renal failure caused by the use of simvastatin in a 54-year-old patient with diabetes mellitus and hypertension is described.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Drug toxicity: Idiosyncratic Reactions
Nephrotic Syndrome I : Introduction
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test